ClinicalTrials.Veeva

Menu

Follow-Up of Ureteral Stones ≤4 mm

R

Region Skane

Status

Invitation-only

Conditions

Kidney Stone

Study type

Observational

Funder types

Other

Identifiers

NCT07176026
2024-04897-01

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the proportion of ureteral stones ≤4 mm that pass spontaneously within 4 and 8 weeks and assess if pain, blood test (S-creatinine), stone size, stone location and hydronephrosis can predict stone passage. The participants will be asked to fill in a questionare regarding symptoms, give a blood test and undergo a follow-up computed tomography.

Full description

All patients with a diagnosis of ureteral stone ≤4 mm at the Emergency Department in Helsingborg will be asked to participate. If they give consent data regarding age, gender, stone size, stone location, hydronephrosis, S-creatinine, treatments and results from the follow up CT is extraced from the medical records.

Enrollment

1,600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients with acute renal colic where a CT within 24 hours shows an ureteral stone ≤ 4mm and there is no need for acute intervention.

Exclusion criteria

  • Those who decline to participate, those who are put under guardianship or is less than 18 years old.

Trial design

1,600 participants in 1 patient group

Follow-up with S-creatine, questionnaire and CT

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems